Karyopharm Therapeutics


Karyopharm Therapeutics  Stock Quote
$19.46 $0.21 1.1%
Price as of July 2, 2020, 10:27 a.m. EDT View Interactive KPTI Charts

Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of drugs directed against nuclear transport targets for the treatment of cancer and other major diseases.

Interactive Chart

News & Analysis: Karyopharm Therapeutics


Market Moves


Biotech's Most Volatile Binary Events for Q1

Risk-taking investors flock to biotech for its constant flow of events that can spike or crush the stock prices of the companies developing the latest therapies.